View in EDS

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.

Saved in:
Bibliographic Details
Title: Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Authors: Guery, Benoit1, Menichetti, Francesco2, Anttila, Veli-Jukka3, Adomakoh, Nicholas4, Georgopali, Areti4, Karas, Andreas4, Kazeem, Gbenga4, Longshaw, Chris4, Palacios-Fabrega, Jose Alejandro4, Aguado, Jose Maria5, Bisnauthsing, Karen6, Goldenberg, Simon D6, Cornely, Oliver A7, Vehreschild, Maria J G T8, EXTEND Clinical Study Group (CORPORATE AUTHOR)
Source: Lancet Infectious Diseases. Mar2018, Vol. 18 Issue 3, p296-307. 12p.
Database: Academic Search Ultimate
Description
ISSN:14733099
DOI:10.1016/S1473-3099(17)30751-X